Ross Bridget A

SEC Form 4 insider trading activity

Ross Bridget A has filed 6 SEC Form 4 filings (11 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: May 11, 2026.

On the most recent filing, Ross Bridget A is listed as Director at LEMAITRE VASCULAR INC. Inside the rolling window, Ross Bridget A reported no open-market purchases and 1 open-market sale totaling $560K in LMAT.

Companies traded

Other insiders at LMAT

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$560K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
LMAT
Ross Bridget A
Sale$560KMay 11SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Ross Bridget A made?

Ross Bridget A has filed 6 SEC Form 4 filings (11 transaction rows) across 1 company since 2025.

Which companies does Ross Bridget A trade?

Ross Bridget A has filed SEC Form 4 disclosures for 1 company, including LMAT.

When was Ross Bridget A's most recent SEC Form 4 filing?

Ross Bridget A's most recent SEC Form 4 filing on Tracefour is dated May 11, 2026.

What is Ross Bridget A's total buy and sell value in the current window?

Inside the rolling retention window, Ross Bridget A bought $0 and sold $560K based on SEC Form 4 filings.

What was Ross Bridget A's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 5,044 LMAT shares on 2026-05-07, worth $560K, per SEC Form 4 filings.